2015
DOI: 10.1007/s10517-015-3113-4
|View full text |Cite
|
Sign up to set email alerts
|

Production and Analysis of Biological Properties of Recombinant Human Apolipoprotein A-I

Abstract: Production of recombinant human apolipoprotein A-I (apoA-I) in E. coli cells is described and its biological properties are compared with those of natural protein. Recombinant apoA-I was isolated as a chimeric polypeptide and then processed to a mature form apoA-I (rapo-I). We studied the ability of the resulting protein to penetrate into hepatocyte nuclei and regulate the rate of DNA biosynthesis in complex with estriol. Penetration of rapoA-I conjugated with FITC into hepatocyte nuclei was demonstrated. rapo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2018
2018
2018
2018

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 7 publications
0
1
0
Order By: Relevance
“…Of note, the yield of untagged WT‐ApoA‐I, obtained by using the method here described, is about 70% higher than the previously reported methods for the recombinant expression of native ApoA‐I, in both E. coli and Pichia pastoris. In addition, the yields of purified G26R‐ApoA‐I, L174S‐ApoA‐I, and L178H‐ApoA‐I variants, by using the same culture conditions and purification protocol, were determined to be in the same range as the WT protein (Table ), which indicates that the protocol can successfully be employed for amyloidogenic ApoA‐I variants in general.…”
Section: Resultsmentioning
confidence: 87%
“…Of note, the yield of untagged WT‐ApoA‐I, obtained by using the method here described, is about 70% higher than the previously reported methods for the recombinant expression of native ApoA‐I, in both E. coli and Pichia pastoris. In addition, the yields of purified G26R‐ApoA‐I, L174S‐ApoA‐I, and L178H‐ApoA‐I variants, by using the same culture conditions and purification protocol, were determined to be in the same range as the WT protein (Table ), which indicates that the protocol can successfully be employed for amyloidogenic ApoA‐I variants in general.…”
Section: Resultsmentioning
confidence: 87%